SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002613
Filing Date
2020-04-28
Accepted
2020-04-27 18:43:25
Documents
6
Period of Report
2020-06-11
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241485zdef14a.htm DEF 14A 420449
2 G533806.JPG g533806.jpg GRAPHIC 13904
3 G310595.JPG g310595.jpg GRAPHIC 6739
4 G21763BM01I001.GIF g21763bm01i001.gif GRAPHIC 63513
5 G21763BM03I001.GIF g21763bm03i001.gif GRAPHIC 131286
6 G21763BM05I001.GIF g21763bm05i001.gif GRAPHIC 103188
  Complete submission text file 0001047469-20-002613.txt   860891
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38650 | Film No.: 20821599
SIC: 2834 Pharmaceutical Preparations